Pituitary & hypothalamus

Insulin-like growth factor-I and symptoms of acromegaly according to time since somatostatin receptor ligand injection

Eur J EndocrinolPublished Prospective observational study

Authors' conclusion

IGF-I concentrations increased according to time since SRL injection. Patient-reported outcomes fluctuated, correlating with IGF-I and sαKL changes. Measuring IGF-I at the end of the injection cycle is advisable. Decreases in SRL concentration suggest phase-based differences in IGF-I concentrations. These findings inform personalized approaches to acromegaly, with titration of therapy based on individual IGF-I and/or PROMs fluctuation.

Study context

Population
Patients with acromegaly receiving monthly long-acting somatostatin receptor ligands (SRLs)
Participants
20 patients
Exposure
Late vs early phase of the SRL injection cycle
Outcome
IGF-I concentration (LC-MS and IDS-iSYS)
Follow-up
Cycle 2
Methodological details2 monthly injection cycles, early (week 1) vs late (week 4) phase sampling, IGF-I by LC-MS and IDS-iSYS immunoassay
  • 2 monthly injection cycles
  • Early (week 1) vs late (week 4) phase sampling
  • IGF-I by LC-MS and IDS-iSYS immunoassay

Main finding

As reported in the abstract

  • Late phase vs Early phase: P = 0.045
  • Late phase vs Early phase: P = 0.023

Observational data: associations, not effects.

Further findings

OutcomeP value
SRL concentrationLower in late phaseP = 0.008

PASQ score · cycle 1

PASQ score week 4 (worse)
18.10 ± 11.96
PASQ score week 2; P vs week 4
15.53 ± 9.94; P = .011
PASQ score week 3; P vs week 4
15.00 ± 12.49; P = .021

Correlations of changes (Δ)

ΔSRL vs ΔIGF-I IDS-iSYS
r = −0.385, P = .047
ΔsαKL vs ΔPASQ score
r = 0.337, P = .034
ΔsαKL vs swelling
r = 0.335, P = .035
ΔACROQoL physical significantly correlated with ΔIGF-I

Original publication

Insulin-like growth factor-I and symptoms of acromegaly according to time since somatostatin receptor ligand injection. Eur J Endocrinol. Published 26 September 2025. doi:10.1093/ejendo/lvaf200

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.